应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SKYE Skye Bioscience Inc.
休市中 09-11 16:00:00 EDT
2.04
-0.04
-1.92%
盘后
2.00
-0.04
-1.96%
19:31 EDT
最高
2.09
最低
1.99
成交量
6.62万
今开
2.08
昨收
2.08
日振幅
4.81%
总市值
895.74万
流通市值
585.27万
总股本
439.09万
成交额
13.39万
换手率
2.31%
流通股本
286.90万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Skye Bioscience Inc.首席财务官John P. Sharp宣布辞职,9月8日正式生效,SEC文件披露
美股速递 · 09-12 04:15
Skye Bioscience Inc.首席财务官John P. Sharp宣布辞职,9月8日正式生效,SEC文件披露
Skye Bioscience与Redmile Biopharma Investments III签署2200万美元证券购买协议——SEC文件披露
美股速递 · 08-25
Skye Bioscience与Redmile Biopharma Investments III签署2200万美元证券购买协议——SEC文件披露
Skye Bioscience:合并后公司现金储备预计可支撑运营至2029年,Rxc008二期数据预计2028年下半年公布
美股速递 · 08-14
Skye Bioscience:合并后公司现金储备预计可支撑运营至2029年,Rxc008二期数据预计2028年下半年公布
Skye Bioscience股东将获CVR:交易结束后12个月内有权收取Nimacimab净收益的90%
美股速递 · 08-14
Skye Bioscience股东将获CVR:交易结束后12个月内有权收取Nimacimab净收益的90%
Skye Bioscience交易后股权结构:Skye持股5.38%,Redx持46.17%,融资投资者持48.45%
美股速递 · 08-14
Skye Bioscience交易后股权结构:Skye持股5.38%,Redx持46.17%,融资投资者持48.45%
Skye Bioscience Inc. - 临床研究委员会批准启动第二组(600毫克静脉注射)入组,此前第一组安全性评估结果良好
美股速递 · 05-20
Skye Bioscience Inc. - 临床研究委员会批准启动第二组(600毫克静脉注射)入组,此前第一组安全性评估结果良好
Skye宣布基于队列1前四名受试者良好安全性数据,队列评审委员会批准开启队列2
美股速递 · 05-20
Skye宣布基于队列1前四名受试者良好安全性数据,队列评审委员会批准开启队列2
Skye Bioscience, Inc.盘中异动 快速跳水6.01%
市场透视 · 2025-02-19
Skye Bioscience, Inc.盘中异动 快速跳水6.01%
Skye Bioscience, Inc.盘中异动 临近午盘股价大涨6.63%报3.04美元
市场透视 · 2025-02-14
Skye Bioscience, Inc.盘中异动 临近午盘股价大涨6.63%报3.04美元
Skye Bioscience, Inc.盘中异动 快速下跌9.62%报3.10美元
市场透视 · 2025-02-11
Skye Bioscience, Inc.盘中异动 快速下跌9.62%报3.10美元
Skye Bioscience, Inc.盘中异动 股价大涨5.41%报3.31美元
市场透视 · 2025-02-11
Skye Bioscience, Inc.盘中异动 股价大涨5.41%报3.31美元
Skye Bioscience, Inc.盘中异动 早盘快速上涨5.03%
市场透视 · 2025-02-07
Skye Bioscience, Inc.盘中异动 早盘快速上涨5.03%
Skye Bioscience, Inc.盘中异动 股价大涨6.01%报3.09美元
市场透视 · 2025-02-06
Skye Bioscience, Inc.盘中异动 股价大涨6.01%报3.09美元
Skye Bioscience, Inc.盘中异动 大幅下跌5.15%
市场透视 · 2025-02-05
Skye Bioscience, Inc.盘中异动 大幅下跌5.15%
Skye Bioscience, Inc.盘中异动 早盘急速拉升8.50%
市场透视 · 2025-02-03
Skye Bioscience, Inc.盘中异动 早盘急速拉升8.50%
Skye Bioscience, Inc.盘中异动 早盘急速上涨6.13%报3.98美元
市场透视 · 2025-01-31
Skye Bioscience, Inc.盘中异动 早盘急速上涨6.13%报3.98美元
Skye Bioscience, Inc.盘中异动 早盘快速拉升5.54%报3.62美元
市场透视 · 2025-01-30
Skye Bioscience, Inc.盘中异动 早盘快速拉升5.54%报3.62美元
Skye Bioscience, Inc.盘中异动 股价大涨5.33%报2.84美元
市场透视 · 2025-01-29
Skye Bioscience, Inc.盘中异动 股价大涨5.33%报2.84美元
Skye Bioscience, Inc.盘中异动 股价大涨6.17%报2.75美元
市场透视 · 2025-01-28
Skye Bioscience, Inc.盘中异动 股价大涨6.17%报2.75美元
Skye Bioscience, Inc.盘中异动 早盘大幅下挫6.12%报2.61美元
市场透视 · 2025-01-27
Skye Bioscience, Inc.盘中异动 早盘大幅下挫6.12%报2.61美元
加载更多
公司概况
公司名称:
Skye Bioscience Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Skye Bioscience, Inc.于2011年3月16日在内华达州注册成立。该公司是一家临床阶段的生物制药公司,其使命是率先开发新药,释放ECS的制药潜力。他们的临床资产专注于CB1的调节,为代谢紊乱、炎症、纤维化和神经退行性变(如肥胖和青光眼)引起的疾病提供新的治疗方法和替代品。
发行价格:
--
{"stockData":{"symbol":"SKYE","market":"US","secType":"STK","nameCN":"Skye Bioscience Inc.","latestPrice":2.04,"timestamp":1789156800000,"preClose":2.08,"halted":0,"volume":66179,"hourTrading":{"tag":"盘后","latestPrice":2,"preClose":2.04,"latestTime":"19:31 EDT","volume":779,"amount":1560.0325,"timestamp":1789169499812,"change":-0.04,"changeRate":-0.019608,"amplitude":0.019608},"delay":0,"changeRate":-0.019230769230769246,"floatShares":2868950,"shares":4390860,"eps":-10.239864,"marketStatus":"休市中","change":-0.04,"latestTime":"09-11 16:00:00 EDT","open":2.08,"high":2.09,"low":1.99,"amount":133880.5405456,"amplitude":0.048077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.239864,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"symbolChange":{"newSymbol":"SKYED","executeDate":"2023-09-08"},"adr":0,"exchange":"NASDAQ","adjPreClose":2.08,"preHourTrading":{"tag":"盘前","latestPrice":2,"preClose":2.08,"latestTime":"09:24 EDT","volume":1677,"amount":3408.3602904,"timestamp":1789133068353,"change":-0.08,"changeRate":-0.038462,"amplitude":0.0625},"postHourTrading":{"tag":"盘后","latestPrice":2,"preClose":2.04,"latestTime":"19:31 EDT","volume":779,"amount":1560.0325,"timestamp":1789169499812,"change":-0.04,"changeRate":-0.019608,"amplitude":0.019608},"volumeRatio":0.6220251752789923,"impliedVol":0.9132,"impliedVolPercentile":0.2395},"requestUrl":"/m/hq/s/SKYE","defaultTab":"news","newsList":[{"id":"1113240693","title":"Skye Bioscience Inc.首席财务官John P. Sharp宣布辞职,9月8日正式生效,SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1113240693","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113240693?lang=zh_cn&edition=full","pubTime":"2026-09-12 04:15","pubTimestamp":1789157710,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会的最新文件披露,Skye Bioscience Inc.宣布了一项重要人事变动。公司首席财务官兼主要财务负责人John P. Sharp已正式提交辞呈。这一人事调整将于2026年9月8日正式生效。此番高管变动消息通过SEC的官方申报文件公之于众,引发市场关注。据悉,Sharp的离职生效日期已明确锁定在2026年9月8日。截至目前,Skye Bioscience Inc.尚未就新任CFO的任命事宜发布进一步说明。投资者正密切关注公司后续的应对举措与管理层补位进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182683501","title":"Skye Bioscience与Redmile Biopharma Investments III签署2200万美元证券购买协议——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1182683501","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182683501?lang=zh_cn&edition=full","pubTime":"2026-08-25 04:04","pubTimestamp":1787601850,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.日前通过美国证券交易委员会文件正式披露,该公司已与Redmile Biopharma Investments III达成一项价值2200万美元的证券购买协议。这一战略性融资安排标志着Skye Bioscience在生物制药领域的发展迈出了重要一步。根据协议条款,Redmile Biopharma Investments III将以认购方式参与本轮融资。证券购买协议的签署,意味着Skye Bioscience将获得用于推进其核心研发项目、扩大临床试验规模以及补充营运资金的重要财务资源。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118976368","title":"Skye Bioscience:合并后公司现金储备预计可支撑运营至2029年,Rxc008二期数据预计2028年下半年公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1118976368","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118976368?lang=zh_cn&edition=full","pubTime":"2026-08-14 21:39","pubTimestamp":1786714767,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc. 宣布,合并后的公司现金储备预计将足以维持运营至2029年。同时,其核心药物候选Rxc008的二期临床数据,预计将在2028年下半年对外公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136838339","title":"Skye Bioscience股东将获CVR:交易结束后12个月内有权收取Nimacimab净收益的90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136838339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136838339?lang=zh_cn&edition=full","pubTime":"2026-08-14 21:38","pubTimestamp":1786714705,"startTime":"0","endTime":"0","summary":"Skye Bioscience宣布,其股东将在交易完成后的12个月内,获得一项或有价值权(CVR),该权益涵盖Nimacimab项目净收益的90%。这一安排为投资者提供了明确的收益分配机制,旨在确保股东能够从该资产未来的商业化成果中直接受益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130885897","title":"Skye Bioscience交易后股权结构:Skye持股5.38%,Redx持46.17%,融资投资者持48.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130885897","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130885897?lang=zh_cn&edition=full","pubTime":"2026-08-14 21:36","pubTimestamp":1786714569,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc.在交易完成后的新公司中,其自身持股比例仅为5.38%。相比之下,Redx的持股比例高达46.17%,而参与融资的投资者则总计持有48.45%的股份。这一股权分配格局,清晰揭示了各方在合并实体中的权重大小。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199526390","title":"Skye Bioscience Inc. - 临床研究委员会批准启动第二组(600毫克静脉注射)入组,此前第一组安全性评估结果良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1199526390","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199526390?lang=zh_cn&edition=full","pubTime":"2026-05-20 19:01","pubTimestamp":1779274904,"startTime":"0","endTime":"0","summary":"在完成对第一组受试者的安全性评估并获得良好反馈后,临床研究委员会已正式批准Skye Bioscience Inc.启动其研究项目的第二组患者入组工作。该组别将采用600毫克的静脉注射剂量方案。这一决定标志着该药物临床开发进程向前迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155074624","title":"Skye宣布基于队列1前四名受试者良好安全性数据,队列评审委员会批准开启队列2","url":"https://stock-news.laohu8.com/highlight/detail?id=1155074624","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155074624?lang=zh_cn&edition=full","pubTime":"2026-05-20 19:00","pubTimestamp":1779274829,"startTime":"0","endTime":"0","summary":"Skye Bioscience Inc. 宣布,其队列评审委员会已批准开启临床试验的队列2。这一决定是基于从队列1中首批接受治疗的四名参与者所获得的积极安全性数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512962111","title":"Skye Bioscience, Inc.盘中异动 快速跳水6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512962111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512962111?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:14","pubTimestamp":1739906081,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时14分,Skye Bioscience, Inc.股票出现波动,股价大幅跳水6.01%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体涨幅为0.95%。其相关个股中,Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大,Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃,换手率分别为840.04%、208.50%、168.28%,振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.,振幅分别为148.75%、92.00%、79.17%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031441988a2a2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031441988a2a2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511152040","title":"Skye Bioscience, Inc.盘中异动 临近午盘股价大涨6.63%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511152040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511152040?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:38","pubTimestamp":1739464710,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时38分,Skye Bioscience, Inc.股票出现波动,股价快速上涨6.63%。截至发稿,该股报3.04美元/股,成交量1.8639万股,换手率0.06%,振幅6.14%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214003830abcdcb06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214003830abcdcb06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510333098","title":"Skye Bioscience, Inc.盘中异动 快速下跌9.62%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510333098?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:14","pubTimestamp":1739286855,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时14分,Skye Bioscience, Inc.股票出现波动,股价大幅下挫9.62%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体跌幅为1.52%。其相关个股中,Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2544.19%、825.94%、338.91%,振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.,振幅分别为52.11%、43.92%、37.99%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231415961f5018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231415961f5018&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139","OCEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510086093","title":"Skye Bioscience, Inc.盘中异动 股价大涨5.41%报3.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510086093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510086093?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:05","pubTimestamp":1739207122,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时05分,Skye Bioscience, Inc.股票出现异动,股价急速上涨5.41%。截至发稿,该股报3.31美元/股,成交量6.7361万股,换手率0.22%,振幅6.92%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体跌幅为0.25%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010522a240c223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010522a240c223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744745","title":"Skye Bioscience, Inc.盘中异动 早盘快速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744745","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509744745?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:40","pubTimestamp":1738939204,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时40分,Skye Bioscience, Inc.股票出现波动,股价急速上涨5.03%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028 Cl A涨幅较大,Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃,换手率分别为1717.95%、52.33%、38.10%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为130.43%、50.97%、20.91%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224005987daf2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207224005987daf2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509203364","title":"Skye Bioscience, Inc.盘中异动 股价大涨6.01%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509203364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509203364?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:15","pubTimestamp":1738854944,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时15分,Skye Bioscience, Inc.股票出现异动,股价急速上涨6.01%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,Lipella Pharmaceuticals Inc.、Azitra Inc、Transcode Therapeutics, Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为5233.13%、1204.05%、130.03%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为98.06%、39.93%、36.09%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206231544987c9688&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206231544987c9688&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509928210","title":"Skye Bioscience, Inc.盘中异动 大幅下跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509928210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509928210?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:32","pubTimestamp":1738765926,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时32分,Skye Bioscience, Inc.股票出现波动,股价快速跳水5.15%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体涨幅为0.80%。其相关个股中,Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.较为活跃,换手率分别为2669.24%、598.88%、588.13%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Eyepoint Pharmaceuticals, Inc.、Oragenics Inc.,振幅分别为16.82%、11.81%、9.75%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223206a23a7a90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223206a23a7a90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","KTTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508141831","title":"Skye Bioscience, Inc.盘中异动 早盘急速拉升8.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508141831?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593167,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分,Skye Bioscience, Inc.股票出现波动,股价急速拉升8.50%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体跌幅为0.51%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大,Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃,换手率分别为319.55%、229.78%、126.66%,振幅较大的相关个股有Hcw Biologics Inc.、Briacell Therapeutics Corp.、Briacell Therapeutics Corp C/Wts 24/02/2025,振幅分别为35.77%、12.95%、12.28%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322324798796f2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322324798796f2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507966635","title":"Skye Bioscience, Inc.盘中异动 早盘急速上涨6.13%报3.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507966635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507966635?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:37","pubTimestamp":1738334231,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时37分,Skye Bioscience, Inc.股票出现波动,股价快速上涨6.13%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。其相关个股中,Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃,换手率分别为1421.87%、266.60%、64.50%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Nls Pharmaceutics Ltd.,振幅分别为62.40%、42.27%、30.81%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223711a2354358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223711a2354358&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507622262","title":"Skye Bioscience, Inc.盘中异动 早盘快速拉升5.54%报3.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507622262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507622262?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:10","pubTimestamp":1738249822,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时10分,Skye Bioscience, Inc.股票出现异动,股价急速拉升5.54%。截至发稿,该股报3.62美元/股,成交量6.7146万股,换手率0.22%,振幅7.87%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302310229614420c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501302310229614420c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507631417","title":"Skye Bioscience, Inc.盘中异动 股价大涨5.33%报2.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507631417?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:33","pubTimestamp":1738161211,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时33分,Skye Bioscience, Inc.股票出现异动,股价急速上涨5.33%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.涨幅较大,Silexion Therapeutics Corp、60 Degrees Pharmaceuticals, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为2058.38%、1489.04%、626.02%,振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Ocean Biomedical, Inc.,振幅分别为114.29%、50.00%、30.73%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223331961395fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223331961395fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506992510","title":"Skye Bioscience, Inc.盘中异动 股价大涨6.17%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506992510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506992510?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:37","pubTimestamp":1738078654,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时37分,Skye Bioscience, Inc.股票出现异动,股价大幅拉升6.17%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,Silexion Therapeutics Corp、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大,Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为3800.52%、2721.45%、260.36%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ,振幅分别为122.16%、82.74%、61.62%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128233735abbb74ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128233735abbb74ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SKYE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506301408","title":"Skye Bioscience, Inc.盘中异动 早盘大幅下挫6.12%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506301408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506301408?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:50","pubTimestamp":1737993040,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时50分,Skye Bioscience, Inc.股票出现异动,股价大幅下挫6.12%。Skye Bioscience, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。其相关个股中,Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、89Bio, Inc.涨幅较大,Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃,换手率分别为1918.40%、367.40%、214.27%,振幅较大的相关个股有Onconetix, Inc.、Dogwood Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为85.35%、75.00%、65.16%。Skye Bioscience, Inc.公司简介:Skye Bioscience Inc 是一家位于加利福尼亚州圣迭戈的临床前制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127235040a2317ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127235040a2317ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SKYE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.skyebioscience.com","stockEarnings":[{"period":"1week","weight":0.0968},{"period":"1month","weight":-0.5354},{"period":"3month","weight":-0.6761},{"period":"6month","weight":-0.6138},{"period":"1year","weight":-0.9401},{"period":"ytd","weight":-0.6599}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Skye Bioscience, Inc.于2011年3月16日在内华达州注册成立。该公司是一家临床阶段的生物制药公司,其使命是率先开发新药,释放ECS的制药潜力。他们的临床资产专注于CB1的调节,为代谢紊乱、炎症、纤维化和神经退行性变(如肥胖和青光眼)引起的疾病提供新的治疗方法和替代品。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.392456},{"month":2,"riseRate":0.333333,"avgChangeRate":0.405082},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.151124},{"month":4,"riseRate":0.5,"avgChangeRate":0.066911},{"month":5,"riseRate":0.5,"avgChangeRate":-0.010396},{"month":6,"riseRate":0.5,"avgChangeRate":0.207605},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.097359},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.169077},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.070737},{"month":10,"riseRate":0.2,"avgChangeRate":-0.245291},{"month":11,"riseRate":0.2,"avgChangeRate":-0.107928},{"month":12,"riseRate":0.2,"avgChangeRate":-0.107415}],"exchange":"NASDAQ","name":"Skye Bioscience Inc.","nameEN":"Skye Bioscience Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Skye Bioscience Inc.(SKYE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Skye Bioscience Inc.(SKYE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Skye Bioscience Inc.,SKYE,Skye Bioscience Inc.股票,Skye Bioscience Inc.股票老虎,Skye Bioscience Inc.股票老虎国际,Skye Bioscience Inc.行情,Skye Bioscience Inc.股票行情,Skye Bioscience Inc.股价,Skye Bioscience Inc.股市,Skye Bioscience Inc.股票价格,Skye Bioscience Inc.股票交易,Skye Bioscience Inc.股票购买,Skye Bioscience Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Skye Bioscience Inc.(SKYE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Skye Bioscience Inc.(SKYE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}